CVS HEALTH Corp
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)
Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%
Cvs Health Pharmacy & Consumer Wellness Revenue by Line
Pharmacy & Consumer Wellness Revenue by Line — Other (MinuteClinic / Clinical) ($M)
Cvs Health Pharmacy & Consumer Wellness Revenue by Line: $628M in Q2 2026, up 7.9% from a year earlier.
Latest, Q2 2026
628
Period ended Jun 30, 2026
Change on a year earlier
+7.9%
582 in Q2 2025
History
32 quarters
Since Q3 2018
Sources
28
Documents cited below
Where the Q2 2026 figure comes from
“|| Other | 628 | 582 | 1,235 | 1,175 | 46 | 7.9 | % | 60 | 5.1 | %”
Source: CVS Health 10-Q (2026-08-05) ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pharmacy & Consumer Wellness Revenue by Line — Other (MinuteClinic / Clinical) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 628 | +7.9% | CVS Health 10-Q (2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 607 | +2.4% | CVS Health 10-Q (2026-05-06) ↗ |
| Q4 2025 | Dec 31, 2025 | 629 | +2.3% | CVS Health 8-K (2026-02-10) ↗ |
| Q3 2025 | Sep 30, 2025 | 594 | +5.9% | CVS Health 10-Q (2025-10-29) ↗ |
| Q2 2025 | Jun 30, 2025 | 582 | +7.0% | CVS Health 10-Q (2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 593 | +3.9% | CVS Health 10-Q (2026-05-06) ↗ |
| Q4 2024 | Dec 31, 2024 | 615 | +5.1% | CVS Health 8-K (2026-02-10) ↗ |
| Q3 2024 | Sep 30, 2024 | 561 | +6.7% | CVS Health 10-Q (2025-10-29) ↗ |
| Q2 2024 | Jun 30, 2024 | 544 | +0.7% | CVS Health 10-Q (2025-07-31) ↗ |
| Q1 2024 | Mar 31, 2024 | 571 | +4.2% | CVS Health 10-Q (2025-05-01) ↗ |
| Q4 2023 | Dec 31, 2023 | 585 | +0.7% | CVS Health 8-K (2025-02-12) ↗ |
| Q3 2023 | Sep 30, 2023 | 526 | -9.6% | CVS Health 10-Q (2024-11-06) ↗ |
| Q2 2023 | Jun 30, 2023 | 540 | -7.8% | CVS Health 10-Q (2024-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 548 | -48.7% | CVS Health 10-Q (2024-05-01) ↗ |
| Q4 2022 | Dec 31, 2022 | 581 | -17.8% | CVS Health 8-K (2024-02-07) ↗ |
| Q3 2022 | Sep 30, 2022 | 582 | -9.5% | CVS Health 10-Q (2023-11-01) ↗ |
| Q2 2022 | Jun 30, 2022 | 586 | -2.5% | CVS Health 10-Q (2023-08-02) ↗ |
| Q1 2022 | Mar 31, 2022 | 1,069 | +52.5% | CVS Health 10-Q (2023-05-03) ↗ |
| Q4 2021 | Dec 31, 2021 | 707 | +6.3% | CVS Health 8-K (2023-02-08) ↗ |
| Q3 2021 | Sep 30, 2021 | 643 | +70.6% | CVS Health 10-Q (2022-11-02) ↗ |
| Q2 2021 | Jun 30, 2021 | 601 | +332.4% | CVS Health 10-Q (2022-08-03) ↗ |
| Q1 2021 | Mar 31, 2021 | 701 | +276.9% | CVS Health 10-Q (2022-05-04) ↗ |
| Q4 2020 | Dec 31, 2020 | 665 | +230.8% | CVS Health 8-K (2022-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 377 | +128.5% | CVS Health 10-Q (2021-11-03) ↗ |
| Q2 2020 | Jun 30, 2020 | 139 | -22.8% | CVS Health 10-Q (2021-08-04) ↗ |
| Q1 2020 | Mar 31, 2020 | 186 | -6.1% | CVS Health 10-Q (2021-05-04) ↗ |
| Q4 2019 | Dec 31, 2019 | 201 | -5.2% | CVS Health 8-K (2021-02-16) ↗ |
| Q3 2019 | Sep 30, 2019 | 165 | -6.2% | CVS Health 10-Q (2020-11-06) ↗ |
| Q2 2019 | Jun 30, 2019 | 180 | – | CVS Health 10-Q (2020-08-05) ↗ |
| Q1 2019 | Mar 31, 2019 | 198 | – | CVS Health 10-Q (2020-05-06) ↗ |
| Q4 2018 | Dec 31, 2018 | 212 | – | CVS Health 8-K (2020-02-12) ↗ |
| Q3 2018 | Sep 30, 2018 | 176 | – | CVS Health 8-K (2019-11-06) ↗ |
Cite this data
StockData. (2026). Cvs Health Pharmacy & Consumer Wellness Revenue by Line ($M), quarterly Q3 2018–Q2 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/pcw-rev-other
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.